Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor
Figure 2
Active GLP-1 levels in plasma of mice 30 minutes after treatment with PSN632408, sitagliptin, or PSN632408 and sitagliptin combination (n = 7 to 8 mice per group).
Plasma GLP-1 levels were significantly higher in mice treated with PSN632408 and sitagliptin combination than in mice treated with PSN632408 alone, (p<0.05).